Matthew Fedowitz
Matthew has a broad intellectual property practice that includes federal district court litigation particularly in the Hatch-Waxman arena, inter partes proceedings at the Patent Trial and Appeal Board, as well as Section 337 investigations at the International Trade Commission.
Matthew also has significant experience in the identification of pharmaceutical products for generic manufacturers; clearance analyses of pharmaceuticals and medical devices; the preparation of patent validity, freedom-to-operate and non-infringement opinions; developing strategies with regard to REMS (Risk Evaluation and Mitigation Strategies) designated pharmaceuticals; counseling on patent prosecution strategy and portfolio management in the U.S and abroad; reexaminations; reissues; and due diligence analysis for patent licensing and corporate transactions.
Formerly a patent examiner at the United States Patent & Trademark Office,Matthew was responsible for patent applications relating to heterocyclic organic chemistry in the pharmaceutical and carbohydrate fields.

Other Team Members